Streetbeat News

Analyst Ratings

FUN

Keybanc analyst Robert Aurand has maintained an Overweight rating on Cedar Fair (NYSE:FUN) and increased the price target from $49 to $52.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 1:30 pm

APPN

Keybanc analyst Thomas Blakey has maintained an Overweight rating on Appian (NASDAQ:APPN) and increased the price target from $45 to $50.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 1:26 pm

ALB

Keybanc analyst Aleksey Yefremov has maintained an Overweight rating on Albemarle (ALB) but lowered the price target from $199 to $178.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 1:24 pm

COIN

Coinbase Global's shares surged following the announcement of better-than-expected Q4 financial results and optimistic Q1 subscription and revenue guidance. Additionally, Canaccord Genuity reaffirmed a Buy rating on COIN and increased its price target from $140 to $240.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 1:19 pm

BE

Keybanc analyst Sophie Karp downgraded Bloom Energy (NYSE:BE) from Overweight to Sector Weight, indicating a neutral outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 1:18 pm

AMAT

Applied Materials Inc (NASDAQ:AMAT) shares surged over 11% in premarket trading following better-than-expected Q1 financial results and optimistic Q2 guidance. The stock has seen a 57% increase over the last year, reaching a new all-time high of $189.47. Technical analysis indicates a bullish outlook with the stock outperforming 84% of its industry peers and trading above its moving averages, suggesting a 'Buy' signal. However, the RSI has entered overbought territory, signaling potential investors to be cautious.

Portfolio Pulse from Surbhi Jain

February 16, 2024 | 1:17 pm

ROKU

Roku's shares declined following the announcement of its Q4 financial results. Additionally, Oppenheimer downgraded Roku's stock from Outperform to Perform, contributing to the negative sentiment.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 1:16 pm

ALNY

Chardan Capital analyst Keay Nakae maintains a Buy rating on Alnylam Pharmaceuticals (NASDAQ:ALNY) but lowers the price target from $250 to $225.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 1:14 pm

SHAK

Shake Shack Inc. (NYSE:SHAK) reported better-than-expected Q4 financial results, with a 20% Y/Y sales increase to $286.2 million and adjusted EPS of 2 cents, surpassing consensus estimates. The company opened 24 new Shacks and projects FY24 revenue of $1.21 billion-$1.25 billion with an operating margin of 20%-21%. Shares surged 26% to $98.40. Analysts from TD Cowen and Wedbush adjusted their price targets for SHAK following the earnings report.

Portfolio Pulse from Avi Kapoor

February 16, 2024 | 1:06 pm

SMCI

Wells Fargo analyst Aaron Rakers initiates coverage on Super Micro Computer (SMCI) with an Equal-Weight rating and a price target of $960.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 1:06 pm